RA CAPITAL MANAGEMENT, L.P. Diversified Active

Location: Boston, MA

CIK: 0001346824 · Show all filings

Period: Q1 2014 (← Previous) (Next →)

Filing Date: May 15, 2014

Total Value: $1.394B (100.0% shares, 0.0% debt)

Holdings (35)

GILD GILEAD SCIENCES INC 12.2%
Value $170M Shares 2,400,000 Share Price $70.86 Est. Cost/Share — Unrealized @ Report Date —
ACAD ACADIA PHARMACEUTICALS INC 9.2%
Value $128M Shares 5,250,000 Share Price $24.33 * Est. Cost/Share $13.77 Unrealized @ Report Date +83.7%
SGMO SANGAMO BIOSCIENCES INC 7.8%
Value $108M Shares 6,000,000 Share Price $18.08 * Est. Cost/Share $9.24 Unrealized @ Report Date +108.6%
SGMO SANGAMO BIOSCIENCES INC 6.8%
Value $94.42M Shares 5,222,053 Share Price $18.08 * Est. Cost/Share $9.24 Unrealized @ Report Date +108.6%
— ACHILLION PHARMACEUTICALS IN 5.5%
Value $76.87M Shares 23,366,007 Share Price $3.29 Est. Cost/Share $4.78 Unrealized @ Report Date —
— DICERNA PHARMACEUTICALS INC 4.9%
Value $68.61M Shares 2,428,571 Share Price $28.25 Est. Cost/Share $28.25 Unrealized @ Report Date —
— DYAX CORP 4.8%
Value $66.78M Shares 7,436,470 Share Price $8.98 Est. Cost/Share $7.78 Unrealized @ Report Date —
— THERAPEUTICSMD INC 4.5%
Value $62.08M Shares 9,838,449 Share Price $6.31 Est. Cost/Share $3.00 Unrealized @ Report Date —
— OPHTHOTECH CORP 4.4%
Value $62M Shares 1,737,856 Share Price $35.67 Est. Cost/Share $32.61 Unrealized @ Report Date —
ENTA ENANTA PHARMACEUTICALS INC 4.4%
Value $61.63M Shares 1,541,078 Share Price $39.99 * Est. Cost/Share $36.32 Unrealized @ Report Date 0.0%
PRTA PROTHENA CORP PLC 4.3%
Value $59.57M Shares 1,554,918 Share Price $38.31 * Est. Cost/Share $15.16 Unrealized @ Report Date +112.7%
— ARROWHEAD RESH CORP 3.5%
Value $48.31M Shares 2,941,916 Share Price $16.42 Est. Cost/Share $9.89 Unrealized @ Report Date —
BCRX BIOCRYST PHARMACEUTICALS 3.3%
Value $46M Shares 4,347,456 Share Price $10.58 Est. Cost/Share $5.07 Unrealized @ Report Date +110.2%
— NOVAVAX INC 3.2%
Value $45.02M Shares 9,938,250 Share Price $4.53 Est. Cost/Share $2.24 Unrealized @ Report Date —
— DYNAVAX TECHNOLOGIES CORP 2.3%
Value $32.33M Shares 17,883,954 Share Price $1.81 Est. Cost/Share $1.67 Unrealized @ Report Date —
— SUNESIS PHARMACEUTICALS INC 2.3%
Value $32.19M Shares 4,869,261 Share Price $6.61 Est. Cost/Share $5.18 Unrealized @ Report Date —
XNCR XENCOR INC 2.3%
Value $31.96M Shares 2,725,000 Share Price $11.73 * Est. Cost/Share $8.58 Unrealized @ Report Date +22.5%
PTCT PTC THERAPEUTICS INC 1.8%
Value $25.66M Shares 981,761 Share Price $26.14 * Est. Cost/Share $19.69 Unrealized @ Report Date +36.5%
— REPROS THERAPEUTICS INC 1.8%
Value $25.53M Shares 1,439,048 Share Price $17.74 Est. Cost/Share $17.74 Unrealized @ Report Date —
— TESARO INC 1.5%
Value $20.64M Shares 700,000 Share Price $29.48 Est. Cost/Share $28.24 Unrealized @ Report Date —
NBIX NEUROCRINE BIOSCIENCES INC 1.3%
Value $18.82M Shares 1,169,084 Share Price $16.10 * Est. Cost/Share $17.10 Unrealized @ Report Date 0.0%
— DERMA SCIENCES INC 1.2%
Value $16.98M Shares 1,339,039 Share Price $12.68 Est. Cost/Share $13.35 Unrealized @ Report Date —
— MIRATI THERAPEUTICS INC 0.9%
Value $12.53M Shares 656,767 Share Price $19.07 Est. Cost/Share $15.39 Unrealized @ Report Date —
— BLUEBIRD BIO INC 0.8%
Value $10.63M Shares 467,418 Share Price $22.74 Est. Cost/Share $26.96 Unrealized @ Report Date —
— PSIVIDA CORP 0.8%
Value $10.48M Shares 2,555,659 Share Price $4.10 Est. Cost/Share $4.04 Unrealized @ Report Date —
— INTERMUNE INC 0.7%
Value $10.07M Shares 300,801 Share Price $33.47 Est. Cost/Share $33.47 Unrealized @ Report Date —
— ACHILLION PHARMACEUTICALS IN 0.7%
Value $9.87M Shares 3,000,000 Share Price $3.29 Est. Cost/Share $4.78 Unrealized @ Report Date —
— FLEXION THERAPEUTICS INC 0.5%
Value $7.403M Shares 450,000 Share Price $16.45 Est. Cost/Share $16.45 Unrealized @ Report Date —
ACAD ACADIA PHARMACEUTICALS INC 0.4%
Value $6.083M Shares 250,000 Share Price $24.33 * Est. Cost/Share $13.77 Unrealized @ Report Date +83.7%
— OCERA THERAPEUTICS INC 0.4%
Value $5.568M Shares 527,797 Share Price $10.55 Est. Cost/Share $11.51 Unrealized @ Report Date —
MGNX MACROGENICS INC 0.4%
Value $5.549M Shares 199,398 Share Price $27.83 * Est. Cost/Share $26.16 Unrealized @ Report Date +35.0%
— ALIMERA SCIENCES INC 0.4%
Value $5.26M Shares 666,667 Share Price $7.89 Est. Cost/Share $7.89 Unrealized @ Report Date —
— MEI PHARMA INC 0.3%
Value $4.545M Shares 408,333 Share Price $11.13 Est. Cost/Share $8.01 Unrealized @ Report Date —
— DYAX CORP 0.3%
Value $4.49M Shares 500,000 Share Price $8.98 Est. Cost/Share $7.78 Unrealized @ Report Date —
— PRANA BIOTECHNOLOGY LTD 0.0%
Value $280K Shares 100,000 Share Price $2.80 Est. Cost/Share — Unrealized @ Report Date —